1型糖尿病儿科患者的临床概况,血糖参数和低血糖之间的关系
Andreea Morar-Stan1, Luminița Dobrotă1, Anișoara Răduțu2
1Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550024 Sibiu, Romania.
Journal of clinical medicine
|February 13, 2026
概括
变化系数 (%CV) 和平均每日葡萄糖 (MDG) 预测1型糖尿病儿童的低血糖风险. 保持%CV低于36%对于最小化儿科患者低血糖风险至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 儿科 儿科 儿科
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 儿童1型糖尿病 (T1D) 的管理需要仔细监测,以防止低血糖.
- 持续葡萄糖监测 (CGM) 为评估血糖控制和风险提供了有价值的数据.
研究的目的:
- 评估临床和CGM参数对儿科T1D患者低血糖风险的预测作用.
- 确定预测轻度和临床显著低血糖的关键指标.
主要方法:
- 一组71名使用CGM的儿科T1D患者被跟踪至少6个月.
- 分析的参数包括年龄,BMI,时间范围,平均每日葡萄糖 (MDG) 和变化系数 (%CV).
- 低血糖症被定义为时间低于3.9 mmol/L (轻度) 和3.0 mmol/L (显著).
主要成果:
- 较低的MDG和较高的%CV显著与低血糖相关.
- %CV成为两种低血糖值的主导预测因素.
- 7岁以下的患者出现低血糖事件的频率最高.
- 特定的%CV (<36.15%) 和MDG (>7.16 mmol/L) 值被确定为降低低血糖的风险.
结论:
- %CV和MDG是儿科T1D中低血糖风险的关键预测因素.
- 建议%CV低于36%,以尽量减少低血糖.
- 年龄也是一个因素,较年轻的儿童 (<7岁) 更容易受到感染.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
279
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism
247
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
247
Hypoglycemia and Glucagon
1.0K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K
Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
311
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
311


